Legal & General Group Plc lifted its stake in shares of Penumbra Inc (NYSE:PEN) by 12.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 15,990 shares of the company’s stock after acquiring an additional 1,746 shares during the period. Legal & General Group Plc’s holdings in Penumbra were worth $1,954,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of Penumbra by 2.7% during the 3rd quarter. Vanguard Group Inc. now owns 2,646,066 shares of the company’s stock worth $396,116,000 after purchasing an additional 68,479 shares during the last quarter. Vanguard Group Inc increased its position in shares of Penumbra by 2.7% during the 3rd quarter. Vanguard Group Inc now owns 2,646,066 shares of the company’s stock worth $396,116,000 after purchasing an additional 68,479 shares during the last quarter. BlackRock Inc. increased its position in shares of Penumbra by 1.1% during the 4th quarter. BlackRock Inc. now owns 1,579,005 shares of the company’s stock worth $192,957,000 after purchasing an additional 17,324 shares during the last quarter. Baillie Gifford & Co. increased its position in shares of Penumbra by 35.8% during the 4th quarter. Baillie Gifford & Co. now owns 906,022 shares of the company’s stock worth $110,715,000 after purchasing an additional 239,008 shares during the last quarter. Finally, Partner Fund Management L.P. increased its position in shares of Penumbra by 24.5% during the 4th quarter. Partner Fund Management L.P. now owns 902,898 shares of the company’s stock worth $110,334,000 after purchasing an additional 177,497 shares during the last quarter. Institutional investors and hedge funds own 81.60% of the company’s stock.

NYSE PEN opened at $128.97 on Friday. The stock has a market capitalization of $4.47 billion, a price-to-earnings ratio of 252.88, a PEG ratio of 7.94 and a beta of 0.80. Penumbra Inc has a 1-year low of $110.84 and a 1-year high of $167.35.

Penumbra (NYSE:PEN) last announced its quarterly earnings data on Tuesday, February 26th. The company reported $0.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.02. The business had revenue of $120.80 million during the quarter, compared to analysts’ expectations of $114.93 million. Penumbra had a return on equity of 4.42% and a net margin of 1.48%. The business’s quarterly revenue was up 25.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.25 EPS. Equities research analysts anticipate that Penumbra Inc will post 0.83 earnings per share for the current year.

Several equities analysts have weighed in on PEN shares. ValuEngine downgraded Penumbra from a “buy” rating to a “hold” rating in a research report on Monday, April 1st. Zacks Investment Research raised Penumbra from a “hold” rating to a “buy” rating and set a $157.00 target price for the company in a research report on Tuesday, March 5th. HC Wainwright reaffirmed a “buy” rating on shares of Penumbra in a research report on Wednesday. Finally, Canaccord Genuity lifted their target price on Penumbra from $138.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, January 30th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Penumbra presently has an average rating of “Buy” and a consensus price target of $143.17.

In other news, CEO Adam Elsesser sold 8,000 shares of Penumbra stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $139.86, for a total value of $1,118,880.00. Following the completion of the transaction, the chief executive officer now owns 1,115,838 shares in the company, valued at approximately $156,061,102.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Arani Bose sold 55,000 shares of Penumbra stock in a transaction dated Thursday, March 21st. The shares were sold at an average price of $160.07, for a total value of $8,803,850.00. The disclosure for this sale can be found here. Insiders sold a total of 82,261 shares of company stock valued at $12,645,766 in the last quarter. Company insiders own 10.70% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://theolympiareport.com/2019/04/20/legal-general-group-plc-has-1-95-million-stake-in-penumbra-inc-pen.html.

About Penumbra

Penumbra, Inc designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands; aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the ACE and the 3D Revascularization Device brands.

Further Reading: How Does the Quiet Period Work?

Want to see what other hedge funds are holding PEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Penumbra Inc (NYSE:PEN).

Institutional Ownership by Quarter for Penumbra (NYSE:PEN)

Receive News & Ratings for Penumbra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra and related companies with MarketBeat.com's FREE daily email newsletter.